News
High precision level of retina scanning makes it an ideal choice for maximum security environments, such as the military and ...
Strong Clinical Evidence Supports Use of the Suprachoroidal Platform in Expanding the Standard of Care for the Treatment of Multiple Macular Diseases ...
2d
TipRanks on MSNCognition Therapeutics presents preclinical data on zervimesine at ARVOCognition Therapeutics (CGTX) reported preclinical data this week at the Association for Research in Vision and Ophthalmology showing the ...
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in ...
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative ...
Phase II trial results indicated that treatment with the firm's antisense oligonucleotide led to stable or improved best-corrected visual acuity.
Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...
Discover the surprising power of pistachios for protecting your vision and overall health. Could a simple snack be the key to ...
6d
Clinical Trials Arena on MSNChengdu Origen and Vanotech dose first subject in gene therapy trial for wet AMDVanotech is the sponsor representative and is responsible for the clinical development programme for the therapy in the US.
The FDA granted regenerative medicine advanced therapy designation to 4D-150 for the treatment of diabetic macular edema, ...
D-150 is a potential backbone therapy that is designed to provide multiyear sustained delivery of anti-VEGF (aflibercept and ...
“My mantra is everybody has the right to good vision,” said Csaky, whose Hungarian name is pronounced chalk-y. “Years ago, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results